 SAN DIEGO, Sept. 08, 2022 GLOBE NEWSWIRE -- Sorrento Therapeutics, Inc. Nasdaq: SRNE, Sorrento today announced that Henry Ji, Ph.D., Chairman, President and Chief Executive Officer, and members of Sorrentos executive team will participate the 20th Annual Morgan Stanley Global Healthcare Conference: 